Free Review Articles on Prostate (Neoplasia)                                 Metatextbook

Freie Reviews über Prostata (Neubildung)                                 Look here for Journal Homepages

  • Prostate (Neoplasia)
  • Leuprorelin
  • Satraplatin
  • Docetaxel
  • GOLM1
  • Neoplasia (Carcinogenesis)
  • Prostate (MRT)
  • Radiopharmacology
  • Vanilloids
  • alpha Methylacyl coenzyme A racemase
  • JAK STAT
  • Prostate (MRS)
  • GSTP1 1
  • Prostatic acid phosphatase
  • PCA3
  • AMACR
  • Kidney (Neoplasm)
  • 17 alpha hydroxylase 17 20 lyase
  • Abiraterone
  • CYP17
  • Bisphosphonates
  • Rhinosporidiosis
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12009Degarelix and its therapeutic potential in the treatment of prostate cancer.



    		+-nlClin Interv Aging 4(-):215-23 (2009)
    22006Role of 5 alpha-reductase inhibitors in the management of prostate cancer.



    		+-nlClin Interv Aging 1(4):425-31 (2006)
    32008The top 13: what family physicians should know about prostate cancer.



    		+-nlCan Fam Physician 54(2):198-203 (2008) Katz A
    42009Active surveillance or active treatment in localized prostate cancer?



    		+-nlDtsch Arztebl Int 106(22):371-6 (2009)
    52009Hormonal therapy in the elderly prostate cancer patient.



    		+-nlDtsch Arztebl Int 106(14):242-7 (2009)
    61995Prostatic intraepithelial neoplasia: a potential precursor lesion of prostatic adenocarcinoma.



    		+-nlYonsei Med J 36(3):215-31 (1995)
    72008Leuprorelin depot injection: patient considerations in the management of prostatic cancer.



    		+-nlTher Clin Risk Manag 4(2):513-26 (2008)
    82007Satraplatin in the treatment of hormone-refractory metastatic prostate cancer.



    		+-nlTher Clin Risk Manag 3(5):877-83 (2007)
    92009Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review.



    		+-nlHealth Technol Assess 13(5):iii, xi-xiii 1-219 (2009)
    102007A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.



    		+-nlHealth Technol Assess 11(2):iii-iv, xv-xviii, 1-179 (2007)
    112006Prostate cancer treatment. The case for radical prostatectomy.



    		+-nlAnn R Coll Surg Engl 88(5):439-42 (2006)
    122005Rectal infiltration by prostatic adenocarcinoma: a report on six patients and review of the literature.



    		+-nlAnn R Coll Surg Engl 87(1):72-3 (2005)
    131953Benign nodular hyperplasia of the prostate; a review.



    		+-nlAnn R Coll Surg Engl 14(2):92-106 (1953)
    142009Stroma-epithelium crosstalk in prostate cancer.



    		+-nlAsian J Androl 11(1):28-35 (2009)
    152009Prostate cancer: diagnosis and staging.



    		+-nlAsian J Androl 11(1):74-80 (2009)
    162009Management of locally advanced prostate cancer.



    		+-nlAsian J Androl 11(1):81-7 (2009)
    172010Androgen receptor signaling and mutations in prostate cancer.



    		+-nlAsian J Androl 12(5):639-57 (2010)
    181997Prostate cancer: a clinical and basic science review.



    		+-nlJ Androl 18(1):15-20 (1997)
    191991Overview of enzyme inhibitors and anti-androgens in prostatic cancer.



    		+-nlJ Androl 12(6):364-71 (1991)
    201991The emerging role of alpha antagonists in the therapy of benign prostatic hyperplasia.



    		+-nlJ Androl 12(6):389-94 (1991)
    211991The pathophysiology of benign prostatic hyperplasia.



    		+-nlJ Androl 12(6):356-63 (1991)
    221991The origin and development of benign prostatic hyperplasia. An age-dependent process.



    		+-nlJ Androl 12(6):348-55 (1991)
    232008Clinical utility of prostate carcinoma molecular diagnostic tests.



    		+-nlRev Urol 10(1):44-69 (2008)
    242006Treatment- and disease-related complications of prostate cancer.



    		+-nlRev Urol 8 Suppl 2(-):S56-67 (2006)
    252005Addressing the needs of the high-risk prostate cancer patient.



    		+-nlRev Urol 7 Suppl 5(-):S18-28 (2005)
    262005Maximum androgen blockade: a clinical update.



    		+-nlRev Urol 7 Suppl 5(-):S13-7 (2005)
    272004A critical review of maximal androgen blockade for advanced prostate cancer.



    		+-nlRev Urol 6 Suppl 8(-):S18-23 (2004)
    282009Brachytherapy for prostate cancer: a systematic review.



    		+-nlAdv Urol -(-):327945 (2009)
    292009Modalities for imaging of prostate cancer.



    		+-nlAdv Urol -(-):818065 (2009)
    301998Malignant changes in the prostate with ageing.



    		+-nlBr J Urol 82 Suppl 1(-):47-58 (1998)
    311997The concept of evolution in the pathogenesis and treatment of prostate cancer.



    		+-nlBr J Urol 79 Suppl 2(-):9-17 (1997)
    322008Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.



    		+-nlNeoplasia 10(11):1285-94 (2008)
    332007Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.



    		+-nlNeoplasia 9(6):455-63 (2007)
    342006Maximal androgen blockade for the treatment of metastatic prostate cancer--a systematic review.



    		+-nlCurr Oncol 13(3):81-93 (2006)
    352010Update on options for treatment of metastatic castration-resistant prostate cancer.



    		+-nlOnco Targets Ther 3(-):39-51 (2010)
    362008Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 19 Suppl 2(-):ii45-6 (2008)
    372004Prostate cancer management.



    		+-nlAnn Oncol 15 Suppl 4(-):iv307-12 (2004)
    382002Treatment options in hormone resistant prostate cancer.



    		+-nlAnn Oncol 13 Suppl 4(-):95-102 (2002)
    392002Prostate cancer: management of advanced disease.



    		+-nlAnn Oncol 13 Suppl 4(-):89-94 (2002)
    402002Management of early prostate cancer.



    		+-nlAnn Oncol 13 Suppl 4(-):83-7 (2002)
    412008Management of complications of prostate cancer treatment.



    		+-nlCA Cancer J Clin 58(4):196-213 (2008)
    422002The current state of hormonal therapy for prostate cancer.



    		+-nlCA Cancer J Clin 52(3):154-79 (2002)
    432000External beam radiation therapy for prostate cancer.



    		+-nlCA Cancer J Clin 50(6):349-75; quiz 376-9 (2000) Horwitz EM
    442000Modern prostate brachytherapy.



    		+-nlCA Cancer J Clin 50(6):380-93 (2000) Ragde H
    451999Contemporary results of anatomic radical prostatectomy.



    		+-nlCA Cancer J Clin 49(5):282-96 (1999) Catalona WJ
    461995Brachytherapy for prostate cancer.



    		+-nlCA Cancer J Clin 45(3):165-78 (1995) Porter AT
    472008An updated catalog of prostate cancer predictive tools.



    		+-nlCancer 113(11):3075-99 (2008)
    482007Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate.



    		+-nlCancer 109(10):2011-5 (2007)
    492007The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review.



    		+-nlCancer 109(1):13-24 (2007)
    502005Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy: clinical and translational issues.



    		+-nlCancer 104(5):891-905 (2005)
    512004Human prostate cancer risk factors.



    		+-nlCancer 101(10 Suppl):2371-490 (2004)
    522000Novel strategies and therapeutics for the treatment of prostate carcinoma.



    		+-nlCancer 89(6):1329-48 (2000)
    531997The natural history of clinical prostate carcinoma.



    		+-nlCancer 80(5):827-33 (1997)
    542010Promoter hypermethylation in prostate cancer.



    		+-nlCancer Control 17(4):245-55 (2010)
    552010Emerging technologies in prostate cancer radiation therapy: improving the therapeutic window.



    		+-nlCancer Control 17(4):223-32 (2010)
    562010Premalignant and malignant prostate lesions: pathologic review.



    		+-nlCancer Control 17(4):214-22 (2010)
    572007High-intensity focused ultrasound (HIFU) for prostate cancer.



    		+-nlCancer Control 14(3):244-9 (2007)
    582007Modern brachytherapy for treatment of prostate cancer.



    		+-nlCancer Control 14(3):238-43 (2007)
    592007Review of primary and salvage cryoablation for prostate cancer.



    		+-nlCancer Control 14(3):231-7 (2007)
    602006Novel agents and targets in managing patients with metastatic prostate cancer.



    		+-nlCancer Control 13(3):194-8 (2006)
    612006The role of external-beam radiation therapy in the treatment of clinically localized prostate cancer.



    		+-nlCancer Control 13(3):188-93 (2006)
    622004Management of androgen-independent prostate cancer.



    		+-nlCancer Control 11(6):364-73 (2004)
    632001Prostate adenocarcinoma: cellular and molecular abnormalities.



    		+-nlCancer Control 8(6):551-61 (2001)
    642001NCCN: New chemotherapeutic approaches to hormone refractory prostate cancer.



    		+-nlCancer Control 8(6 Suppl 2):62-5 (2001)
    652001The evolving role of prostate brachytherapy.



    		+-nlCancer Control 8(2):163-70 (2001)
    662001Transrectal ultrasound and biopsy in the early diagnosis of prostate cancer.



    		+-nlCancer Control 8(2):141-50 (2001)
    672006Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.



    		+-nlCarcinogenesis 27(1):1-22 (2006)
    682005Prostate carcinogenesis and inflammation: emerging insights.



    		+-nlCarcinogenesis 26(7):1170-81 (2005)
    691994Prostate cancer progression. Implications of histopathology.



    		+-nlAm J Pathol 145(5):983-93 (1994)
    702000Hormonal therapy for advanced prostate cancer.



    		+-nlAnn Intern Med 132(7):584-5 (2000) Vaughn DJ
    712000Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.



    		+-nlAnn Intern Med 132(7):566-77 (2000)
    722007Early versus delayed endocrine therapy for prostate cancer.



    		+-nlEndocr Relat Cancer 14(1):1-11 (2007)
    732005Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours.



    		+-nlEndocr Relat Cancer 12(2):229-44 (2005)
    742004Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer.



    		+-nlEndocr Relat Cancer 11(3):459-76 (2004)
    751999Neuroendocrine cells in tumour growth of the prostate.



    		+-nlEndocr Relat Cancer 6(4):503-19 (1999)
    761999Prostate cancer: molecular biology of early progression to androgen independence.



    		+-nlEndocr Relat Cancer 6(4):487-502 (1999)
    772000Molecular genetics of prostate cancer.



    		+-nlGenes Dev 14(19):2410-34 (2000)
    782008Approach to the prostate cancer patient with bone disease.



    		+-nlJ Clin Endocrinol Metab 93(1):2-7 (2008)
    792001Clinical review 134: The endocrinology of prostate cancer.



    		+-nlJ Clin Endocrinol Metab 86(8):3467-77 (2001)
    802005Molecular pathology of prostate cancer.



    		+-nlJ Clin Pathol 58(7):673-84 (2005)
    812005Androgen deprivation therapy for prostate cancer.



    		+-nlJAMA 294(2):238-44 (2005)
    822008High-dose-rate brachytherapy in the curative treatment of patients with localized prostate cancer.



    		+-nlMayo Clin Proc 83(12):1364-72 (2008)
    832005Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease.



    		+-nlMayo Clin Proc 80(7):899-907 (2005)
    842005External beam radiotherapy as curative treatment of prostate cancer.



    		+-nlMayo Clin Proc 80(7):883-98 (2005)
    852004Tissue ablation technologies for localized prostate cancer.



    		+-nlMayo Clin Proc 79(12):1547-55 (2004)
    862004Minimally invasive radical prostatectomy.



    		+-nlMayo Clin Proc 79(9):1169-80 (2004)
    872004Unusual subtypes of prostate cancer.



    		+-nlMod Pathol 17(3):316-27 (2004)
    882004Gleason grading and prognostic factors in carcinoma of the prostate.



    		+-nlMod Pathol 17(3):292-306 (2004)
    892004Benign mimickers of prostatic adenocarcinoma.



    		+-nlMod Pathol 17(3):328-48 (2004)
    902004Radical prostatectomy for carcinoma of the prostate.



    		+-nlMod Pathol 17(3):349-59 (2004)
    912004Molecular genetics of human prostate cancer.



    		+-nlMod Pathol 17(3):380-8 (2004)
    922004High-grade prostatic intraepithelial neoplasia.



    		+-nlMod Pathol 17(3):360-79 (2004)
    932009Multidisciplinary functional MR imaging for prostate cancer.



    		+-nlKorean J Radiol 10(6):535-51 (2009)
    942008Novel tracers and their development for the imaging of metastatic prostate cancer.



    		+-nlJ Nucl Med 49(12):2031-41 (2008)
    952003PET imaging of prostate cancer with 11C-acetate.



    		+-nlJ Nucl Med 44(4):556-8 (2003) Dimitrakopoulou-Strauss A
    962007Functional MR imaging of prostate cancer.



    		+-nlRadiographics 27(1):63-75; discussion 75-7 (2007)
    972004Complications of prostate cancer treatment: spectrum of imaging findings.



    		+-nlRadiographics 24 Suppl 1(-):S181-94 (2004)
    982004Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.



    		+-nlRadiographics 24 Suppl 1(-):S167-80 (2004)
    992001Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.



    		+-nlCMAJ 164(7):975-81 (2001)
    1001999Prostatic carcinoma.



    		+-nlRadiographics 19(1):185-203 (1999)
    1011990Cystic lesions of the prostate.



    		+-nlRadiographics 10(4):635-50 (1990)
    1022008Pictorial review: Unusual tumours involving the prostate: radiological-pathological findings.



    		+-nlBr J Radiol 81(971):907-15 (2008)
    1032007Imaging prostate cancer: a multidisciplinary perspective.



    		+-nlRadiology 243(1):28-53 (2007)
    1042006Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.



    		+-nlRadiology 239(3):784-92 (2006)
    1052005Gonadotropin-releasing hormone agonists in the treatment of prostate cancer.



    		+-nlEndocr Rev 26(3):361-79 (2005)
    1062004Androgen receptor in prostate cancer.



    		+-nlEndocr Rev 25(2):276-308 (2004)
    1072009Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism.



    		+-nlActa Biomed 80(1):13-20 (2009)
    1082008Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer.



    		+-nlActa Med Okayama 62(1):9-13 (2008)
    1092011[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].



    		+-nlActas Urol Esp 35(10):565-79 (2011)
    1102010Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 21 Suppl 5(-):v129-33 (2010)
    1112010Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials.



    		+-nlAnn Oncol 21(2):312-8 (2010)
    1122010Horizon scanning for novel therapeutics for the treatment of prostate cancer.



    		+-nlAnn Oncol 21 Suppl 7(-):vii43-55 (2010)
    1132005Hormonotherapy of advanced prostate cancer.



    		+-nlAnn Oncol 16 Suppl 4(-):iv80-84 (2005)
    1142009Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.



    		+-nlAnn Oncol 20 Suppl 4(-):76-8 (2009)
    1152009Challenges in clinical prostate cancer: role of imaging.



    		+-nlAJR Am J Roentgenol 192(6):1455-70 (2009)
    1162009Imaging localized prostate cancer: current approaches and new developments.



    		+-nlAJR Am J Roentgenol 192(6):1471-80 (2009)
    1172004Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).



    		+-nlAm J Clin Pathol 122(2):275-89 (2004)
    1182011Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer.



    		+-nlAm J Transl Res 3(2):133-8 (2011)
    1192009Neuroendocrine differentiation in prostate cancer.



    		+-nlAm J Transl Res 1(2):148-62 (2009)
    1202010Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.



    		+-nlBMJ 341():c4543 (2010) Djulbegovic M
    1212011A practical guide to prostate cancer diagnosis and management.



    		+-nlCleve Clin J Med 78(5):321-31 (2011)
    1222010New developments in the medical management of prostate cancer.



    		+-nlMayo Clin Proc 85(1):77-86 (2010)
    1232007Prostate cancer: a practical approach to current management of recurrent disease.



    		+-nlMayo Clin Proc 82(2):243-9 (2007)
    1242007Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide.



    		+-nlRadiology 244(1):196-204 (2007)
    1252007Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.



    		+-nlRadiology 245(2):499-506 (2007)
    1262008Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.



    		+-nlRadiology 246(1):177-84 (2008)
    1272011Pseudosarcomatous fibromyxoid tumor of the prostate.



    		+-nlScientificWorldJournal 11(-):1027-30 (2011)
    1282011Methods to predict and lower the risk of prostate cancer.



    		+-nlScientificWorldJournal 11(-):742-8 (2011)
    1292010PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.



    		+-nlScientificWorldJournal 10(-):1919-31 (2010)
    1302010Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.



    		+-nlDiscov Med 10(52):255-62 (2010)
    1312005Endocrine approaches in the therapy of prostate carcinoma.



    		+-nlHum Reprod Update 11(3):309-17 (2005)
    1322010New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK.



    		+-nlClin Cancer Res 16(13):3322-8 (2010)
    1332009Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer.



    		+-nlClin Cancer Res 15(15):4792-8 (2009)
    1342009Targeting the PI3K/AKT pathway for the treatment of prostate cancer.



    		+-nlClin Cancer Res 15(15):4799-805 (2009)
    1352009Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature.



    		+-nlOncologist 14(8):816-27 (2009)
    1362008Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer.



    		+-nlCancer 112(8):1660-71 (2008)
    1372006Treatment options in lymph node-positive prostate cancer.



    		+-nlCancer 106(12):2531-9 (2006)
    1382007Pten inactivation and the emergence of androgen-independent prostate cancer.



    		+-nlCancer Res 67(14):6535-8 (2007)
    1392009Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven.



    		+-nlCancer Res 69(12):4937-40 (2009)
    1402009Concepts of epigenetics in prostate cancer development.



    		+-nlBr J Cancer 100(2):240-5 (2009)
    1412008Emerging biomarkers for the diagnosis and prognosis of prostate cancer.



    		+-nlClin Chem 54(12):1951-60 (2008)
    1422011Radical prostatectomy versus watchful waiting in early prostate cancer.



    		+-nlN Engl J Med 364(18):1708-17 (2011)
    1432010Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.



    		+-nlHealth Technol Assess 14(47):1-108, iii-iv (2010)
    1442009Molecular mechanisms of castration-resistant prostate cancer progression.



    		+-nlFuture Oncol 5(9):1403-13 (2009)
    1452007My approach to intraductal lesions of the prostate gland.



    		+-nlJ Clin Pathol 60(8):856-65 (2007)
    1462007TMPRSS2-ETS fusion prostate cancer: biological and clinical implications.



    		+-nlJ Clin Pathol 60(11):1185-6 (2007) Demichelis F
    1472007Spindle cell lesions of the adult prostate.



    		+-nlMod Pathol 20(1):148-58 (2007)
    1482007Pathogenesis of prostate cancer and hormone refractory prostate cancer.



    		+-nlIndian J Urol 23(1):35-42 (2007)
    1492007Update in palliative management of hormone refractory cancer of prostate.



    		+-nlIndian J Urol 23(1):43-50 (2007)
    1502007Use of bisphosphonates in prostate cancer: Current status.



    		+-nlIndian J Urol 23(1):51-4 (2007)
    1512007New therapeutic targets in the treatment of prostate cancer.



    		+-nlIndian J Urol 23(1):61-6 (2007)
    1522007Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines.



    		+-nlIndian J Urol 23(1):67-9 (2007)
    1532009Etiopathogenesis of benign prostatic hypeprlasia.



    		+-nlIndian J Urol 25(3):312-7 (2009)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.